Heart Disease Clinical Trials in New York

Showing 381-400 of 585 trials

RecoverLINK Technology Pilot for HF Patients

NCT02815085

The primary objective is to examine feasibility of incorporating RecoverLINK into the standard of care as a function of (i) user engagement, (ii) user satisfaction, and (iii) workflow efficiency. As secondary objectives, the investigators will collect preliminary data to examine the association between patient engagement with the RecoverLINK app and (i) changes in patient knowledge and behavior, and (ii) hospital readmission(s) at 30, 60, and 90-day time periods post-enrollment.

Heart Failure

RecoverLINK46 participantsStarted Feb 2016

New York, New York, United States

TERMINATEDPhase 3< 1 mile

Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery

NCT00458276

Endothelin-1 is a powerful substance that may be involved in causing hemodynamic instability (problems related to unstable blood pressure) during and after open heart surgery. Tezosentan is an investigational intravenous drug that blocks the endothelin receptors. This clinical trial will assess the potential benefit of tezosentan compared with placebo in the treatment of patients undergoing open heart surgery with cardiopulmonary bypass (CPB). Treatment time is from the start of surgery up to 24 hours.

Heart DiseasesHypertension, Pulmonary

Idorsia Pharmaceuticals Ltd.274 participantsStarted Apr 2007

Stanford, California, United States • New York, New York, United States • New York, New York, United States +30 more locations

RecoverLINK Technology Pilot for HF Patients

Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery

Heart Disease Trials in Other Cities

Exercise and Inflammation

Vegan vs AHA Diet on Inflammation and Glucometabolic Profile in Patients With CAD

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion

Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients

Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site

Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients

Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure

Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease

AngioDefender Versus Brachial Artery Ultrasound Imaging

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Intracranial Atherosclerosis and Depression After Coronary Artery Bypass Graft

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

The BOSS Study: An Acute Evaluation of Anatomical and Geometric Changes Using the Bladder on a Stick System (BOSS)

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)

Other Conditions in New York